Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM) explains the differences between bexagliflozin and velagliflozin, and how to determine if a patient is a good candidate ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...